End Stage Renal Failure on Dialysis Clinical Trial
— PA-CKDOfficial title:
A Structured Exercise and Educational Intervention to Increase Physical Activity in Haemodialysis Patients: a Feasibility Study
Verified date | April 2022 |
Source | Oxford Brookes University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There is a well established link between physical inactivity and increased mortality in the general population and across many of the more common disease areas including chronic kidney disease (CKD). Patients with CKD have very high levels of morbidity and mortality and are known to have low fitness levels. Randomised controlled trials of exercise have demonstrated the benefits of physical activity for CKD patients. Despite this, physical activity levels remain low and translating these research findings into clinical practice is challenging. This feasibility study aims to assess the feasibility and acceptability of an instructor led structured exercise programme which includes an educational component to engage and increase physical activity levels in haemodialysis patients attending the Oxford University Hospitals Trust haemodialysis unit. Consented participants will fill in a self reported physical activity questionnaire (Human Activity Profile), partake in functional mobility assessments including (Timed-Up and Go) and a chair based exercise programme. At the end of the study, participants, and nursing staff will undertake a semi-structured interview aimed at understanding acceptability of the intervention. The results of this feasibility study will then be used to inform whether a larger trial in haemodialysis patients is feasible. All questionnaires, physical activity interventions and interviews will be undertaken during routine visits to the haemodialysis unit.
Status | Completed |
Enrollment | 16 |
Est. completion date | May 29, 2020 |
Est. primary completion date | April 27, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - • Participant is willing and able to give informed consent for participation in the trial. - Male or Female, aged 18 years or above. - Undergoing regular haemodialysis (2 or 3 times per week) in the Oxford Main and Tarver Dialysis Units - Is able and willing to comply with all trial requirements. - Willing to allow his or her General Practitioner and consultant, if appropriate, to be notified of participation in the trial. Exclusion Criteria: - Unable to give consent - Poor dialysis compliance - Female participant who is pregnant, lactating or planning pregnancy during the course of the trial. - Participant with life expectancy of less than 1 month and/or receiving palliative care. - Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial. - Planning to leave Oxford Dialysis units within the study trial - Absolute contra-indications to PA including: - Recent significant change in resting ECG suggesting significant ischaemia, recent Myocardial Infarction within 2 days or acute cardiac event - Unstable angina - Uncontrolled cardiac arrhythmia causing symptoms or haemodynamic compromise - Symptomatic severe aortic stenosis - Uncontrolled symptomatic heart failure - Acute pulmonary embolus or infarction - Acute myocarditis or pericarditis - Third degree heart block - Suspected or know dissecting aortic aneurysm - Acute systemic infection, accompanied by fever, body aches or swollen lymph glands |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Oxford University Hospitals NHS FT | Oxford | Oxfordshire |
Lead Sponsor | Collaborator |
---|---|
Oxford Brookes University | Oxford University Hospitals NHS Trust |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Semi structured interviews and questionnaires targeted to determine participant acceptability of PA intervention and the people delivering it | Interviews with patients and staff | Interviews should last no longer than an hour and will be conducted at month 3 post baseline | |
Secondary | Change is being assessed 3 metre Timed Up and Go | Functional activity, 1 minute to complete | Change from baseline functional mobility at 6 months | |
Secondary | Change is being assessed 10 metre walk test | Functional activity, 5 minutes to complete | Change from baseline functional mobility at 6 months | |
Secondary | Change is being assessed Hand grip strength | Functional strength, 2 minutes to complete. | Change from baseline arm strength at 6 months | |
Secondary | Change is being assessed Wrist worn accelerometery data | Accelerometers to be worn for one week at 3 time points to assess daily activity | Change from baseline of activity at 6 months | |
Secondary | Change is being assessed EQ-5D-3L questionnaire | This is a self-completing short questionnaire comprising questions on the following 5 areas: mobility, self-care and daily activities. This should take no longer to complete. | Change from baseline quality of life at 6 months | |
Secondary | Change is being assessed IPOS Renal questionnaire | This is self-completing questionnaire comprising of 11 questions assessing renal symptoms with other items for additional concerns. 10 minutes to complete | Change from baseline quality of life at 6 months | |
Secondary | Change is being assessed Human Activity profile questionnaire | This tick box questionnaire consists of 94 questions and seeks to determine the activities participants currently do. 15 minutes to complete | Change from baseline of physical activity at 6 months | |
Secondary | Falls and Fractures questionnaire | We wish to know if participants have had any falls or fractures in the last 6 months and assess baseline mobility level.
Questions are based on Yes or No Referred medical falls clinic? Referred therapy falls clinic? Referred non-FLS primary care No. of falls, slips, trips in last 12 months= Indoor Gait: range from 1-2 Outdoor Gait: range from 1-2 Any Indoor falls- yes or no Broken bones in adult hood= Yes/No |
Change from baseline | |
Secondary | Client Service Receipt Inventory Questionnaire | Participants will be given as short tick-box questionnaire to collect information regarding other hospitals facilities they have visited including General Practitioner visits over the last 6 months. This will exclude routine visits to haemodialysis.
Hospital departments and services used in last 6 months- No=0 Yes=1 Use of community care services in last 6 months- No=0 Yes=1 Diagnostic tests in last 6 months- No=0 Yes=1 Use of mobility aids in last 6 months- No=0 Yes=1 Adaptations at home in last 6 months-No=0 Yes=1 Changes in informal care in last 6 months months- No=0 Yes=1 Journeys to receive care in last 6 months No=0 Yes=1 Current occupation range of 1-7 |
Change from baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01561118 -
DiaSport - Endurance-orientated Training Program With Children and Adolescents on Maintenance Hemodialysis
|
N/A | |
Withdrawn |
NCT03645720 -
The Prognosis of Graft Using Plastic Cannula in Hemodialysis
|
N/A | |
Active, not recruiting |
NCT02598635 -
Effects of Cholecalciferol on Osteoprotegerin Levels in Patients on Peritoneal Dialysis
|
Phase 4 | |
Terminated |
NCT01643733 -
Study on Fistuloplasty Using Flow Measurement Guidance
|
N/A | |
Not yet recruiting |
NCT03169400 -
Theranova Dialyzer and Chronic Kidney Disease - Mineral Bone Disorder (CKD-MBD)
|
N/A | |
Completed |
NCT02439697 -
A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients
|
N/A | |
Completed |
NCT02063490 -
Nurse-led Intervention to Improve Phosphate Binder Adherence
|
N/A | |
Completed |
NCT04106310 -
Theranova vs High-flux HD Comparison
|
N/A | |
Recruiting |
NCT06056102 -
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
|
Phase 1 | |
Completed |
NCT04698512 -
MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial
|
||
Completed |
NCT02819011 -
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
|
Phase 2 | |
Completed |
NCT02484118 -
Hemodialysis Blood Flow and Urea Clearance
|
N/A | |
Enrolling by invitation |
NCT01641757 -
Effect of Non-Surgical Periodontal Therapy on Serum Albumin Levels of Patients on Maintenance Hemodialysis Therapy,
|
Phase 2 | |
Completed |
NCT03172039 -
Antimicrobial Use and Stewardship in an Outpatient Hemodialysis Unit
|
N/A | |
Completed |
NCT03897231 -
Prevalence of Non-adherence to Medication Among Patients on Chronic Hemodialysis
|
||
Withdrawn |
NCT03145662 -
High Pressure Balloon vs Cutting Balloon
|
N/A | |
Completed |
NCT02621918 -
The Effects of Exercise in End-stage Renal Disease Patients Undergoing Hemodialysis
|
N/A | |
Completed |
NCT01356615 -
Low Molecular Weight Heparin for Hemodialysis Anticoagulation
|
N/A | |
Terminated |
NCT01033357 -
Safety Study of the Vascular Wrap Paclitaxel-Eluting Mesh for Hemodialysis Vascular Access
|
N/A | |
Recruiting |
NCT05927532 -
Argyle Safety Fistula Cannula With Anti-reflux Valve Clinical Study
|
N/A |